A detailed history of Clearbridge Investments, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Clearbridge Investments, LLC holds 349,578 shares of GKOS stock, worth $33.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
349,578
Holding current value
$33.9 Million
% of portfolio
0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$96.6 - $161.22 $33.8 Million - $56.4 Million
349,578 New
349,578 $34.4 Million
Q1 2020

May 15, 2020

SELL
$25.53 - $70.14 $20.6 Million - $56.5 Million
-805,377 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$54.18 - $65.64 $5.04 Million - $6.11 Million
93,047 Added 13.06%
805,377 $43.8 Million
Q3 2019

Nov 14, 2019

BUY
$58.58 - $83.91 $27.2 Million - $39 Million
464,715 Added 187.68%
712,330 $44.5 Million
Q2 2019

Aug 14, 2019

BUY
$63.59 - $78.71 $15.7 Million - $19.5 Million
247,615 New
247,615 $0

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.62B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.